Intuitive Surgical, Inc. $ISRG Shares Bought by Assetmark Inc.

Assetmark Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 55,521 shares of the medical equipment provider’s stock after purchasing an additional 1,614 shares during the period. Assetmark Inc.’s holdings in Intuitive Surgical were worth $24,831,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Sivia Capital Partners LLC increased its stake in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares during the period. Harbour Investments Inc. lifted its position in Intuitive Surgical by 95.5% in the 2nd quarter. Harbour Investments Inc. now owns 2,976 shares of the medical equipment provider’s stock worth $1,617,000 after buying an additional 1,454 shares in the last quarter. Mutual Advisors LLC boosted its stake in shares of Intuitive Surgical by 5.7% during the 2nd quarter. Mutual Advisors LLC now owns 1,605 shares of the medical equipment provider’s stock valued at $796,000 after buying an additional 86 shares during the period. Finally, Nordea Investment Management AB grew its holdings in shares of Intuitive Surgical by 6.2% during the 2nd quarter. Nordea Investment Management AB now owns 43,921 shares of the medical equipment provider’s stock valued at $23,632,000 after acquiring an additional 2,549 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $485.84 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $609.08. The stock has a fifty day moving average price of $541.62 and a 200 day moving average price of $510.34. The stock has a market cap of $172.54 billion, a P/E ratio of 61.58, a price-to-earnings-growth ratio of 3.76 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the business earned $2.21 earnings per share. The company’s quarterly revenue was up 18.8% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ISRG. Jefferies Financial Group upped their target price on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Leerink Partners increased their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. BTIG Research reaffirmed a “buy” rating and set a $616.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 23rd. Truist Financial boosted their target price on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. Finally, Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $617.23.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 464 shares of Intuitive Surgical stock in a transaction on Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president owned 131 shares in the company, valued at approximately $71,852.19. The trade was a 77.98% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the completion of the transaction, the director directly owned 15,720 shares of the company’s stock, valued at $8,355,494.40. This represents a 15.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 56,189 shares of company stock worth $30,785,441. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.